Annovis Bio
ANVS
8 hedge funds and large institutions have $1.06M invested in Annovis Bio in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
82% more capital invested
Capital invested by funds: $582K → $1.06M (+$478K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
14% more funds holding
Funds holding: 7 → 8 (+1)
0.73% more ownership
Funds ownership: 2.82% → 3.55% (+0.73%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$158K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$62K |
| 3 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$8.26K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$17.1K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$4K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WVP
1
Worth Venture Partners
Fort Lee,
New Jersey
| $607K | -$17.1K | -4,133 | -3% |
|
|
2
Millennium Management
New York
| $166K | +$158K | +38,179 | New |
|
|
ZCA
3
Zeke Capital Advisors
Berwyn,
Pennsylvania
| $120K | – | – | – |
|
|
BFM
4
Boothbay Fund Management
New York
| $65K | +$62K | +15,000 | New |
|
|
KJHP
5
K.J. Harrison & Partners
Toronto,
Ontario, Canada
| $52K | +$8.26K | +2,000 | +20% |
|
|
CC
6
Cannell & Co
New York
| $44K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $4K | +$4.25K | +1,028 | New |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $2K | – | – | – |
|
|
9
Bank of America
Charlotte,
North Carolina
| – | -$4K | -1,225 | Closed |
|
|
10
Victory Capital Management
San Antonio,
Texas
| – | -$2K | -384 | Closed |
|
ANVS Hedge Fund Activity: Q2 2020 in Review
8 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q2 2020, worth a combined $1.06M — up 82% from $582K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ANVS positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $158K. The largest seller was Worth Venture Partners, cutting an estimated $17.1K.
- 8 institutional investors held Annovis Bio (ANVS) as of Q2 2020, up from 7 in Q1 2020.
- Funds reported $1.06M of Annovis Bio stock for Q2 2020, up 82% quarter-over-quarter.
- 3 funds opened new Annovis Bio positions in Q2 2020 and 2 closed out, a net change of +1 holder.
- The largest Annovis Bio buyer in Q2 2020 was Millennium Management, an estimated $158K added.
- The largest Annovis Bio seller in Q2 2020 was Worth Venture Partners, an estimated $17.1K sold.
Based on aggregated 13F filings for Q2 2020.